Back to Blog
Your First Month on GLP-1 Medication: What to Expect Week by Week
GuidesMarch 8, 20268 min read

By Iacob Pastina, Independent Researcher

Your First Month on GLP-1 Medication: What to Expect Week by Week

Starting a GLP-1? Here's a realistic week-by-week breakdown of what happens — from the initial consultation through your first dose escalation.

Summarize this article with

Most GLP-1 patients lose 2-5 pounds in their first month, with noticeable appetite suppression starting within the first 1-2 weeks. Side effects — mainly mild nausea — peak during the first dose escalation at week 4, but 98.1% of GI side effects are mild to moderate. Starting GLP-1 medication is straightforward, but knowing what to expect makes the process smoother. Here's a realistic week-by-week timeline based on standard dose-titration protocols and clinical trial data. Use our dosing timeline tool to see your exact titration schedule by medication, or take the match quiz to find the best provider before you start.

Before You Start: The Consultation

Most telehealth platforms follow a similar process. You'll complete a medical questionnaire covering your weight history, current medications, medical conditions, and goals. A licensed provider reviews your information — usually within 24-48 hours — and determines if you're a candidate.

Some platforms require lab work (metabolic panel, thyroid function) before prescribing. Others include labs as part of the program. Your provider will choose a starting dose — all GLP-1s begin at a low dose to minimize side effects.

Week 1: Starting Dose

You'll start at the lowest available dose. Per the Wegovy prescribing information, injectable semaglutide starts at 0.25mg once weekly. For tirzepatide (Zepbound), it's 2.5mg once weekly.

  • Appetite changes may be subtle or noticeable — everyone responds differently
  • Some people notice reduced food cravings within the first few days
  • Mild nausea is common, especially in the first 24-48 hours after injection
  • You may feel fuller faster during meals
  • Weight loss in week 1 is usually minimal — don't expect dramatic changes yet
Injection tip:Inject into the abdomen, thigh, or upper arm. Rotate injection sites. Room-temperature medication tends to sting less than cold. Most patients report the injection itself is nearly painless with the pre-filled pen devices.

Weeks 2-3: Settling In

By your second and third weeks, your body is adjusting. This is when most people start noticing meaningful appetite reduction. You may find yourself eating smaller portions without trying, or losing interest in snacking between meals.

GI side effects — if you have them — are usually at their mildest on the starting dose. The most common are mild nausea (often around meal times), changes in bowel habits, and occasional bloating. Staying hydrated and eating smaller, more frequent meals helps.

Week 4: First Dose Escalation

After 4 weeks on the starting dose, most protocols escalate to the next level. For semaglutide, that's 0.5mg; for tirzepatide, 5mg. This is when side effects tend to be most noticeable — your body is adjusting to a higher dose.

  • Nausea may return or increase for the first few days at the new dose
  • Appetite suppression typically becomes more pronounced
  • Most people see their first meaningful weight loss (2-5 lbs) by end of month 1
  • Energy levels may fluctuate as your caloric intake naturally decreases
  • Side effects at each new dose level typically peak in the first week then improve

It takes several months of gradual dose escalation to reach the target maintenance dose. Semaglutide takes about 16-20 weeks to reach 2.4mg; tirzepatide takes 16-28 weeks to reach 10-15mg. Don't rush this — the slow escalation is specifically designed to improve tolerability. In clinical trials, 98.1% of GI side effects were mild-to-moderate.

How Much Weight Will You Lose in the First Month?

The clinical trial averages are achieved over 68-72 weeks, not overnight. A realistic timeline:

  • Month 1: 1-3% body weight loss (mostly from reduced food intake)
  • Months 2-4: Weight loss accelerates as doses increase — roughly 1-2% per month
  • Months 4-12: Continued steady loss as you reach maintenance dose
  • Month 12-16: Most patients reach their maximum weight loss on the medication
  • Beyond 16 months: Weight maintenance phase — studies show weight stays off as long as you continue the medication
Key finding:The STEP 4 trial showed that patients who stopped semaglutide after 20 weeks regained about two-thirds of their lost weight within a year. This is not a short-term treatment — most patients benefit from ongoing use.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Information is current as of the publication date but may change.

Affiliate Disclosure: Some links in this article are affiliate links. We may earn a commission if you sign up through our links, at no extra cost to you.

Find Your GLP-1 Provider

Compare 40 verified providers side-by-side.